Essais liés2clinical trials
VilleParislocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05999604

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Ocrelizumab Injection [Ocrevus] SEP Phase 3 NCT05999604 WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial ACTIVE_NOT_RECRUITING
blood sample to analyse AMH level on the serum SEP À vérifier NCT07164924 FERTIMUS — Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility COMPLETED